Clinical Trials

20 enrolled

Breast Neoplasms

NCT03011684 2026-06-04

TALES

309 enrolled

BreastGynecologicHead & Neck

Breast Neoplasms, Infertility

NCT05768139 2026-06-04

PIKALO-1

Phase 1/2 Recruiting

880 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Ovarian Neoplasms, Endometrial Neoplasms

NCT01272037 2026-06-03

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Phase 3 Active not recruiting

5,018 enrolled 14 charts

Carcinoma, Intraductal, Noninfiltrating

NCT06671912 2026-06-02

LoTam

Phase 3 Suspended

1,156 enrolled

Phase 3 Active not recruiting

Breast Carcinoma In Situ

NCT07616973 2026-06-01

LET-CC-TAM

240 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT00310180 2026-05-29

TAILORx

Phase 3 Active not recruiting

10,273 enrolled 14 charts

Phase 2 Active not recruiting

Breast Neoplasms

NCT02311933 2026-05-29

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

81 enrolled 9 charts

Breast Neoplasms

NCT05952557 2026-05-28

CAMBRIA-2

5,500 enrolled

Breast Neoplasms

NCT06492616 2026-05-27

ELEGANT

4,220 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT05472792 2026-05-26

CAMERAN

90 enrolled

Breast Neoplasms

NCT06075953 2026-05-22

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

400 enrolled

Phase 2 Not yet recruiting

Carcinoma, Intraductal, Noninfiltrating

NCT07287098 2026-05-22

preEMBER

600 enrolled

Breast Neoplasms

NCT07349069 2026-05-22

A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer

5,500 enrolled

Breast Neoplasms

NCT06195306 2026-05-20

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

66 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05512364 2026-05-15

TREAT ctDNA

220 enrolled